Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction

This publication has 17 references indexed in Scilit:

• Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
  Heart, 1988
• Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.
  Circulation, 1988
• Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.
  Circulation, 1988
• Relevance of changes in blood fibrinolytic and coagulation parameters during thrombolytic therapy
  The American Journal of Medicine, 1987
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• Prevention of Myocardial Damage in Acute Myocardial Ischemia by Early Treatment with Intravenous Streptokinase
  New England Journal of Medicine, 1985
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980
• Extra-adrenal effect of ACTH on fibrinogen synthesis
  American Journal of Physiology-Legacy Content, 1973